Migraine: pharmacotherapy in the emergency department.
Migraine can be a disabling condition for the sufferer. For the small number of patients who fail home therapy and seek treatment in an emergency department, there are a number of therapeutic options. This paper reviews the evidence regarding the effectiveness and safety of the following therapies: the phenothiazines, lignocaine (lidocaine), ketorolac, the ergot alkaloids, metoclopramide, the "triptans", haloperidol, pethidine and magnesium. Based on available evidence, the most effective agents seem to be prochlorperazine, chlorpromazine and sumatriptan, each of which have achieved greater then 70% efficacy in a number of studies.
Kelly
A M
AM
Department of Emergency Medicine, Western Hospital, Footscray, Australia. Anne-Maree.Kelly@nwhcn.org.au
D000701:Analgesics, Opioid / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D004636:Emergency Service, Hospital; D004638:Emergency Treatment; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008614:Meperidine / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy*; D010640:Phenothiazines
D000701:Analgesics, Opioid; D014150:Antipsychotic Agents; D010640:Phenothiazines; D008614:Meperidine; D006220:Haloperidol